Dr Laurence de Leval is Professor of Pathology and Head of the Pathology Department at the Lausanne University Hospital. She graduated M.D. at the University of Liège, Belgium, in 1994, where she trained in pathology and obtained a PhD degree in experimental pathology in 1998. She completed a 2-year postdoctoral fellowship in hematopathology at the Massachusetts General Hospital in Boston. From 2000 to 2009 she was staff pathologist at the University Hospital, Liège and senior researcher of the Belgian National Fund for Scientific research.
She received the Benjamin Castleman award presented by the USCAP in 2008 for her discovery of the follicular helper T-cell (TFH) derivation of angioimmunoblastic T-cell lymphoma, and was awarded the Inbev-Baillet Latour Fund Prize for Clinical Research in 2009. She has authored more than 170 scientific publications and several chapters for reference textbooks in pathology and hematology.
She is a member of the executive board and of the pathology group of the LYSA (the Lymphoma Study Association) and was elected member of the International Lymphoma Study Group in 2011. She is a member of the International Thymic Malignancy Group (ITMIG). Her diagnostic activities are mainly in hematopathology and molecular pathology. Her research is currently focused on the characterization of the pathological spectrum of lymphomas derived from TFH cells, and deciphering the molecular mechanisms underlying oncogenesis in NK/T-cell malignancies.
Other interests include implementing and optimizing tools for the molecular diagnosis of hematological malignancies and other cancers.